Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE

(2015) Sharon M. Moe et al.   CIRCULATION

FGF23 protein expression in coronary arteries is associated with impaired kidney function

(2014) Natalie A. van Venrooij et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality

(2012) Victoria Shalhoub et al.   JOURNAL OF CLINICAL INVESTIGATION

Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community

(2012) Johan Ärnlöv et al.   KIDNEY INTERNATIONAL

C-terminal FGF23 is a strong predictor of survival in systolic heart failure

(2012) Damien Gruson et al.   PEPTIDES

Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure

(2011) Max Plischke et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

(2011) Tamara Isakova   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

FGF23 induces left ventricular hypertrophy

(2011) Christian Faul et al.   JOURNAL OF CLINICAL INVESTIGATION

Plasma Klotho and Cardiovascular Disease in Adults

(2011) Richard D. Semba et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis

(2011) J. Kendrick et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

(2009) Orlando M. Gutiérrez et al.   CIRCULATION

Regulation of Fibroblast Growth Factor 23 Production in Bone in Uremic Rats

(2009) Fumie Saji et al.   NEPHRON PHYSIOLOGY